Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
167
4.670
Why?
Human papillomavirus 16
11
2021
44
3.690
Why?
Uterine Cervical Neoplasms
10
2024
276
3.440
Why?
Papillomavirus Vaccines
7
2021
67
3.360
Why?
Oncogene Proteins, Viral
11
2011
52
2.510
Why?
Papillomaviridae
7
2019
102
2.370
Why?
Repressor Proteins
9
2011
149
2.150
Why?
Epitopes, T-Lymphocyte
7
2018
25
1.950
Why?
Cancer Vaccines
3
2021
78
1.640
Why?
T-Lymphocytes
6
2021
328
1.460
Why?
Candida
4
2018
60
1.370
Why?
CD8-Positive T-Lymphocytes
6
2018
124
1.330
Why?
Cervix Uteri
3
2021
42
0.900
Why?
Uterine Cervical Dysplasia
2
2015
49
0.850
Why?
Immunity, Cellular
4
2013
69
0.750
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
75
0.740
Why?
Epitopes
2
2015
59
0.720
Why?
Langerhans Cells
3
2018
11
0.720
Why?
Neoplasms
2
2021
1233
0.690
Why?
Viral Load
2
2019
76
0.670
Why?
Health Education
1
2021
153
0.660
Why?
Cell Cycle Checkpoints
1
2019
30
0.660
Why?
HLA Antigens
4
2006
53
0.630
Why?
Colorectal Neoplasms
1
2021
253
0.590
Why?
CD4-Positive T-Lymphocytes
3
2018
157
0.580
Why?
Humans
40
2024
49898
0.580
Why?
Adult
20
2021
13346
0.570
Why?
Female
28
2024
26560
0.560
Why?
Health Knowledge, Attitudes, Practice
1
2021
488
0.540
Why?
Plasma Exchange
2
2014
22
0.520
Why?
T-Lymphocytes, Regulatory
2
2016
82
0.500
Why?
Cross Protection
1
2015
5
0.500
Why?
Colposcopy
1
2015
18
0.490
Why?
Interleukin-12
2
2018
29
0.480
Why?
Adjuvants, Immunologic
2
2018
51
0.480
Why?
Immunity, Innate
1
2015
104
0.460
Why?
Interferon-gamma
2
2012
176
0.450
Why?
Health
1
2013
22
0.450
Why?
Lectins, C-Type
1
2013
30
0.450
Why?
Papillomavirus E7 Proteins
8
2018
31
0.450
Why?
Young Adult
9
2021
4029
0.440
Why?
Patient Selection
1
2015
254
0.430
Why?
Middle Aged
14
2021
12285
0.430
Why?
Afibrinogenemia
1
2012
4
0.410
Why?
Enzyme-Linked Immunospot Assay
1
2012
2
0.400
Why?
T-Lymphocytes, Cytotoxic
4
2009
65
0.400
Why?
Breast Neoplasms
1
2021
1183
0.390
Why?
Cell Proliferation
5
2021
986
0.380
Why?
Vaginal Smears
3
2021
28
0.370
Why?
Early Detection of Cancer
3
2021
163
0.370
Why?
Warts
1
2010
13
0.370
Why?
Plateletpheresis
1
2010
7
0.360
Why?
Antigens, Fungal
1
2010
23
0.360
Why?
Blood Preservation
1
2010
26
0.360
Why?
Dermatitis
1
2010
36
0.360
Why?
Blood Proteins
1
2010
77
0.350
Why?
Anaphylaxis
1
2010
71
0.340
Why?
Cells, Cultured
5
2021
1587
0.330
Why?
Antigens, Viral
2
2009
43
0.320
Why?
Immunotherapy
1
2010
235
0.310
Why?
Telemedicine
1
2015
465
0.310
Why?
Human papillomavirus 18
1
2008
9
0.310
Why?
Blood Platelets
1
2010
249
0.300
Why?
Host-Pathogen Interactions
2
2021
136
0.290
Why?
Dendritic Cells
1
2008
133
0.280
Why?
Vaccinia virus
1
2007
6
0.280
Why?
Immunoenzyme Techniques
1
2007
141
0.280
Why?
Immunophenotyping
1
2007
109
0.280
Why?
Cell Line, Tumor
5
2021
1388
0.240
Why?
Isoantibodies
1
2004
27
0.240
Why?
Neoplasm Grading
2
2021
123
0.240
Why?
Aged
9
2021
9447
0.240
Why?
Lead
1
2004
33
0.230
Why?
Infant, Very Low Birth Weight
1
2004
48
0.230
Why?
Neutropenia
1
2004
114
0.230
Why?
Oropharyngeal Neoplasms
1
2024
18
0.220
Why?
DNA, Viral
3
2011
133
0.220
Why?
Anus Neoplasms
1
2024
24
0.220
Why?
Coinfection
1
2024
42
0.220
Why?
Blood Transfusion
1
2004
125
0.220
Why?
Penile Neoplasms
1
2024
45
0.220
Why?
Adolescent
5
2021
6414
0.210
Why?
High-Throughput Nucleotide Sequencing
2
2021
168
0.210
Why?
Antibody Formation
1
2002
51
0.200
Why?
Capsid Proteins
1
2002
24
0.200
Why?
Clone Cells
3
2007
78
0.200
Why?
Genes, T-Cell Receptor
1
2021
5
0.200
Why?
Treatment Outcome
3
2021
5176
0.200
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.190
Why?
Cytokines
2
2016
607
0.190
Why?
Pilot Projects
2
2021
702
0.190
Why?
Remission Induction
1
2021
205
0.190
Why?
Mass Screening
2
2021
346
0.190
Why?
Cystadenocarcinoma, Serous
1
2021
71
0.190
Why?
Lymphocyte Activation
1
2021
171
0.180
Why?
Videotape Recording
1
2021
26
0.180
Why?
Left-Right Determination Factors
1
2020
1
0.180
Why?
Nodal Protein
1
2020
3
0.180
Why?
Amino Acid Sequence
3
2008
579
0.180
Why?
Mammography
1
2021
98
0.180
Why?
Focus Groups
1
2021
189
0.170
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
234
0.170
Why?
Male
10
2024
25437
0.170
Why?
Metagenome
1
2019
40
0.170
Why?
Glioblastoma
1
2020
88
0.160
Why?
Dose-Response Relationship, Drug
2
2016
1354
0.160
Why?
Parenteral Nutrition
1
2019
26
0.160
Why?
Feasibility Studies
1
2021
382
0.160
Why?
Up-Regulation
1
2020
446
0.160
Why?
Health Behavior
1
2021
249
0.160
Why?
Transplantation Conditioning
1
2019
82
0.150
Why?
DNA
1
2021
543
0.150
Why?
Time Factors
2
2021
2891
0.150
Why?
Bacteria
1
2019
219
0.150
Why?
Leukocytes, Mononuclear
2
2016
112
0.150
Why?
Multiple Myeloma
1
2012
2915
0.150
Why?
HLA-B Antigens
2
2008
7
0.150
Why?
Age Factors
1
2021
1092
0.140
Why?
Cell Line
2
2012
1010
0.140
Why?
Brain Neoplasms
1
2020
282
0.140
Why?
Ovarian Neoplasms
1
2021
450
0.140
Why?
Histocompatibility Antigens Class II
2
2008
37
0.140
Why?
Vaccines, Subunit
1
2016
15
0.130
Why?
Head and Neck Neoplasms
1
2019
281
0.130
Why?
Body Mass Index
1
2019
648
0.130
Why?
Molecular Sequence Data
2
2008
799
0.120
Why?
Adaptive Immunity
1
2015
31
0.120
Why?
Chromatography, Liquid
1
2016
225
0.120
Why?
Leukocyte Count
2
2004
71
0.120
Why?
Peptides
2
2006
220
0.120
Why?
Tandem Mass Spectrometry
1
2016
227
0.120
Why?
Proteome
1
2016
153
0.120
Why?
Factor VIII
1
2014
23
0.120
Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
15
0.120
Why?
ADAM Proteins
1
2014
20
0.120
Why?
Antigens, CD1
1
2013
9
0.110
Why?
Mannose-Binding Lectins
1
2013
10
0.110
Why?
Receptors, Pattern Recognition
1
2013
4
0.110
Why?
Indicators and Reagents
1
2013
37
0.110
Why?
Intracellular Space
1
2013
25
0.110
Why?
Skin Tests
1
2013
55
0.110
Why?
Hematopoietic Stem Cell Transplantation
1
2019
554
0.110
Why?
Vaccination
1
2016
275
0.110
Why?
Cadherins
1
2013
64
0.110
Why?
Proteomics
1
2016
292
0.110
Why?
Communication
1
2015
246
0.100
Why?
Rural Health Services
1
2015
168
0.100
Why?
Research Design
1
2015
344
0.100
Why?
Antigens, CD
1
2013
215
0.100
Why?
Socioeconomic Factors
1
2015
583
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
579
0.100
Why?
Longitudinal Studies
2
2005
693
0.100
Why?
Injections, Intralesional
1
2010
31
0.090
Why?
Isotonic Solutions
1
2010
17
0.090
Why?
Platelet Transfusion
1
2010
28
0.090
Why?
P-Selectin
1
2010
32
0.090
Why?
Sodium Chloride
1
2010
56
0.090
Why?
Platelet Aggregation
1
2010
71
0.090
Why?
Platelet Activation
1
2010
47
0.090
Why?
Hypersensitivity
1
2010
76
0.080
Why?
Retrospective Studies
3
2019
6123
0.080
Why?
Polymerase Chain Reaction
1
2010
456
0.080
Why?
HLA-A Antigens
1
2008
10
0.080
Why?
Antigen Presentation
1
2008
25
0.080
Why?
Immunologic Memory
1
2008
29
0.080
Why?
Histocompatibility Antigens Class I
1
2008
44
0.080
Why?
Signal Transduction
2
2020
1608
0.070
Why?
DNA, Recombinant
1
2007
15
0.070
Why?
Animals
2
2019
13100
0.070
Why?
Genes, MHC Class I
1
2006
11
0.070
Why?
Arkansas
1
2013
1987
0.070
Why?
Binding, Competitive
1
2006
94
0.070
Why?
Neoplasm Staging
1
2008
749
0.060
Why?
Calgranulin B
1
2005
4
0.060
Why?
Calgranulin A
1
2005
5
0.060
Why?
Immunomagnetic Separation
1
2004
7
0.060
Why?
Epitope Mapping
1
2004
6
0.060
Why?
Risk Factors
1
2013
3604
0.060
Why?
Phosphorylation
2
2020
526
0.050
Why?
Sensitivity and Specificity
1
2005
858
0.050
Why?
Tumor Virus Infections
1
2002
46
0.050
Why?
Antibodies, Viral
1
2002
93
0.050
Why?
Lactobacillus
1
2021
6
0.050
Why?
Immunoglobulin G
1
2002
184
0.050
Why?
SOX Transcription Factors
1
2021
4
0.050
Why?
Neuroendocrine Cells
1
2021
10
0.050
Why?
Biological Specimen Banks
1
2021
21
0.050
Why?
Cytodiagnosis
1
2021
42
0.050
Why?
Cytoplasm
1
2021
93
0.050
Why?
Cobalt
1
2020
16
0.050
Why?
Cohort Studies
1
2004
1403
0.040
Why?
Recurrence
1
2002
658
0.040
Why?
Vulnerable Populations
1
2020
46
0.040
Why?
Cell Hypoxia
1
2020
82
0.040
Why?
Epithelial-Mesenchymal Transition
1
2020
49
0.040
Why?
Neoplastic Stem Cells
1
2021
100
0.040
Why?
Cell Movement
1
2021
245
0.040
Why?
Community Health Workers
1
2020
51
0.040
Why?
Multivariate Analysis
1
2021
579
0.040
Why?
Parenteral Nutrition, Total
1
2019
31
0.040
Why?
Sequence Analysis, DNA
1
2019
237
0.040
Why?
Cell Survival
1
2020
590
0.040
Why?
Phenotype
1
2021
728
0.040
Why?
Cell Differentiation
1
2021
649
0.040
Why?
Linear Models
1
2019
274
0.040
Why?
Models, Biological
1
2021
719
0.040
Why?
Immunity, Humoral
1
2018
22
0.040
Why?
Infant, Newborn
1
2004
2729
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2020
824
0.030
Why?
Prognosis
1
2021
1956
0.030
Why?
Autoantibodies
1
2014
114
0.030
Why?
Immunosuppressive Agents
1
2014
226
0.030
Why?
Mice, Inbred C57BL
1
2018
1777
0.030
Why?
Combined Modality Therapy
1
2014
638
0.030
Why?
Mice
1
2018
5658
0.020
Why?
Casein Kinase II
1
2005
10
0.020
Why?
Cell Division
1
2005
294
0.010
Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description